🇺🇸 FDA
Patent

US 6537998

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

expired A61PA61P5/02

Quick answer

US patent 6537998 (Gonadotropin-releasing hormone receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Mar 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61P, A61P5/02